BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 16642692)

  • 1. [Preventing hypertension with drugs?].
    MMW Fortschr Med; 2006 Mar; 148(13):4-5. PubMed ID: 16642692
    [No Abstract]   [Full Text] [Related]  

  • 2. [In high risk patients also treat high normal blood pressure values!].
    Düsing R
    MMW Fortschr Med; 2006 Mar; 148(13):5. PubMed ID: 16642693
    [No Abstract]   [Full Text] [Related]  

  • 3. Arterial 'prehypertension': a useful concept for drug companies, useless for patients.
    Prescrire Int; 2007 Apr; 16(88):73-5. PubMed ID: 17460859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term effects of candesartan and amlodipine on cardiovascular morbidity and mortality in Japanese high-risk hypertensive patients: the Candesartan Antihypertensive Survival Evaluation in Japan Extension Study (CASE-J Ex).
    Ogihara T; Ueshima K; Nakao K; Fukiyama K; Oba K; Yasuno S; Fujimoto A; Sato T; Matsuoka H; Saruta T;
    Hypertens Res; 2011 Dec; 34(12):1295-301. PubMed ID: 21833000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Investigations of the antihypertensive long-term action of candesartan cilexetil in different dosages under the influence of therapy-free intervals].
    Weisser B; Gerwe M; Braun M; Funken C
    Arzneimittelforschung; 2005; 55(9):505-13. PubMed ID: 16229114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of high-normal blood pressure with angiotensin receptor blockers. TROPHY Study (Trial of Preventing Hypertension)].
    Mann J
    Internist (Berl); 2007 Apr; 48(4):436-8. PubMed ID: 17342351
    [No Abstract]   [Full Text] [Related]  

  • 7. Blood pressure variability: the challenge of variation.
    Marshall TP
    Am J Hypertens; 2008 Jan; 21(1):3-4. PubMed ID: 18091733
    [No Abstract]   [Full Text] [Related]  

  • 8. Candesartan and cognitive decline in older patients with hypertension: a substudy of the SCOPE trial.
    Saxby BK; Harrington F; Wesnes KA; McKeith IG; Ford GA
    Neurology; 2008 May; 70(19 Pt 2):1858-66. PubMed ID: 18458219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin-II-receptor inhibitors in pregnancy.
    Hinsberger A; Wingen AM; Hoyer PF
    Lancet; 2001 May; 357(9268):1620. PubMed ID: 11386315
    [No Abstract]   [Full Text] [Related]  

  • 10. Renin-angiotensin system blockade safely reduces blood pressure in patients with minor ischemic stroke during the acute phase.
    Nakamura T; Tsutsumi Y; Shimizu Y; Uchiyama S
    J Stroke Cerebrovasc Dis; 2010; 19(6):435-40. PubMed ID: 20702114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness analysis of hypertension treatment: controlled release nifedipine and candesartan low-dose combination therapy in patients with essential hypertension--the Nifedipine and Candesartan Combination (NICE-Combi) Study.
    Fujikawa K; Hasebe N; Kikuchi K;
    Hypertens Res; 2005 Jul; 28(7):585-91. PubMed ID: 16335887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of combination therapy with candesartan cilexetil and pioglitazone hydrochloride in patients with hypertension and type 2 diabetes mellitus.
    Kaku K; Enya K; Sugiura K; Totsuka N
    Curr Med Res Opin; 2011 Nov; 27 Suppl 3():73-84. PubMed ID: 22106979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood pressure variability causes spurious identification of hypertension in clinical studies: a computer simulation study.
    Turner MJ; van Schalkwyk JM
    Am J Hypertens; 2008 Jan; 21(1):85-91. PubMed ID: 18091749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A dose-response analysis of candesartan-hydrochlorothiazide combination therapy in patients with hypertension.
    Karlson BW; Zetterstrand S; Olofsson B; Elmfeldt D
    Blood Press; 2009; 18(3):149-56. PubMed ID: 19462314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood pressure lowering does not reduce risk of cardiovascular events in patients at intermediate risk.
    Torjesen I
    BMJ; 2016 Apr; 353():i1899. PubMed ID: 27044631
    [No Abstract]   [Full Text] [Related]  

  • 16. Fixed-dose combination therapy of candesartan cilexetil and amlodipine besilate for the treatment of hypertension in Japan.
    Yasuno S; Fujimoto A; Nakagawa Y; Kuwahara K; Ueshima K
    Expert Rev Cardiovasc Ther; 2012 May; 10(5):577-83. PubMed ID: 22651833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of antihypertensive effect of angiotensin II receptor blockers in patients with essential hypertension by self-measured home blood pressure--HACARARE 300 study].
    Msanobu T;
    Nihon Rinsho; 2009 Oct; 67(10):2013-20. PubMed ID: 19860206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Linear IgA bullous dermatosis induced by angiotensin receptor antagonists.
    Peña-Penabad C; Rodríguez-Lozano J; del Pozo J; García-Silva J; Fonseca E
    Am J Med; 2003 Feb; 114(2):163-4. PubMed ID: 12586244
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of candesartan on cardiovascular outcomes in Japanese hypertensive patients.
    Suzuki H; Kanno Y;
    Hypertens Res; 2005 Apr; 28(4):307-14. PubMed ID: 16138560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the efficacy and tolerability of combination therapy with candesartan cilexetil and amlodipine besilate compared with candesartan cilexetil monotherapy and amlodipine besilate monotherapy in Japanese patients with mild-to-moderate essential hypertension: a multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Rakugi H; Ogihara T; Miyata Y; Sasai K; Totsuka N
    Clin Ther; 2012 Apr; 34(4):838-48. PubMed ID: 22440192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.